International Stem Cell Corporation
ISCO
$0.14
-$0.03-15.15%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 91.30% | 64.77% | 19.29% | -59.54% | -293.71% |
| Total Depreciation and Amortization | 9.50% | 11.34% | 10.42% | 6.19% | 1.01% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -16.01% | -17.87% | -9.87% | -5.06% | 18.15% |
| Change in Net Operating Assets | -435.94% | -57.25% | -24.42% | -26,866.67% | 59.83% |
| Cash from Operations | -139.52% | 107.55% | -16.73% | -98.60% | -70.72% |
| Capital Expenditure | 75.15% | 47.18% | -123.29% | -107.50% | -106.25% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 66.67% | -66.67% | 0.00% | -66.67% | -100.00% |
| Cash from Investing | 74.85% | 44.83% | -116.88% | -106.02% | -106.02% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00% | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -177.24% | -302.17% | -85.10% | -142.32% | -116.10% |